Incidence, temporal trends and prognostic impact of heart failure complicating acute myocardial infarction in the SWEDEHEART registry:

Size: px
Start display at page:

Download "Incidence, temporal trends and prognostic impact of heart failure complicating acute myocardial infarction in the SWEDEHEART registry:"

Transcription

1 Incidence, temporal trends and prognostic impact of heart failure complicating acute myocardial infarction in the SWEDEHEART registry: A study of patients from admitted with an index myocardial infarction Liyew Desta 1, Tomas Jernberg 2, Ida Löfman 2, Claes Hofman-Bang 1, Inger Hagerman 2, Jonas Spaak 1, Hans Persson 1. 1 Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden. 2 Department of Cardiology, Karolinska University Hospital, Huddinge, Stockholm.

2 Nothing to disclose

3 Background Epidemiological features IHD is known as a principal cause of HF. Remarkable changes have taken place in the contributing factors to the incidence of HF. This includes tremondous advances in the treatment practices of ACS. Understanding the epidemiology of HF requires investigation of HF in the setting of AMI. However, there is a paucity of data on temporal trends and prognostic significance of post-mi HF.

4 Conflicting evidence Literature Period N= Trend in post-mi HF Framingham no Published Circulation 1999;100: Framingham Circulation 2008;118: Ezekowitz et al J Am Coll Cardiol. 2009;53:13-20 WHAS1 (Spencer et al) J Am Coll Cardiol. 1999;34: WHAS2 (Goldberg et al) J Am Coll Cardiol. 2004;94: Hellerman et al Am J Epidemiol. 2003;157: Najafi et al Eur J Heart Fail. 2007;9: Shafazand et al Eur J Heart Fail 2011;13: Stöd vår forskning -

5 Thus data on post-mi HF, which are critical to characterization of the contribution of acute MI to the HF epidemic, are currently incomplete warranting the need for our study.

6 Aims: To examine temporal trends in incidence and outcome of heart failure (HF) complicating acute myocardial infarction (AMI).

7 Design, setting and participants: The nationwide coronary care unit registry SWEDEHEART records baseline characteristics, treatments and outcome of consecutive patients with AMI admitted to all hospitals in Sweden. The study includes patients admitted for an index AMI between 1996 and 2008.

8 SWEDEHEART (RIKS-HIA) Include all patients with an AMI at all CCU/ICU in Sweden N = patients National Outcome Registries (National Board of Health and Welfare) Hospital discharge registry Death registry

9 Definition: For the purpose of our study, the diagnosis of HF required: the presence of crackles (Killip class) or use of iv diuretics or use of iv inotropic drugs.

10 Results - demographics Age, y 70,2 71,2 71,3 70,8 Females (%) 35,0 36,8 37,0 37,1 Diabetes (%) 18,9 19,7 19,3 19,1 Hypertension (%) 32,5 35,1 40,9 47 Smokers (%) 21,7 22,4 23,9 23,0 Reperfusion treatment in STEMI pat (%) Medications at discharge (%) 62,8 63,1 63,3 77,1 Beta-blocker 75,0 80,3 84,0 86,5 ACE-I/ARB 36,9 42,8 55,3 68,1 Statins 21,5 47,7 68,3 80,6

11 The incidence of clinical HF during admission for AMI % % STEMI ARR = 22% Clinical HF ARR =18% 28% NSTEMI ARR = 14% p<0.001 for

12 The incidence of pulmonary rales by their grades over the years in the SWEDEHEART registry % Basal Half chest Pulmonary edema

13

14 Pattern of LV dysfunction over the years in the RIKS- HIA population as measured by EF (all AMI) <30 normal %

15 Proportion of HF patients post AMI with HFNEF is steadily increasing EF >=50% ( HF-Yes) N= N= N= N= N= N= % 21,4% 23,1% 25,6% 28,8% 30,1%

16 HR 3.11 (CI ) Adjusted HR 2.09 (CI ) Mortality rate of patients with clinical heart failure complicating acute myocardial infarction during admission observation over 13 years period

17 Mortality rate trends in HF complicating AMI in the SWEDEHEART registry p-value In-hospital mortality 30 days mortality 1 year mortality 19 % 13% < % 17% < % 31% <0.001

18 Conclusion: We found a marked decrease in the incidence of HF complicating AMI between 1996 and This is accompanied by a significant decrease in in-hospital, 30 day and 1 year mortality. The long-term outcome in patients with HF complicating AMI is still poor

19 Thank you! Participating centres in SWEDEHEART Alingsås, Arvika, Avesta, Bollnäs, Borås, Danderyd, Eksjö, Enköping, Eskilstuna, Fagersta, Falun, Gällivare, Gävle, Halmstad, Helsingborg, Hudiksvall, Hässleholm, Jönköping, Kalix, Kalmar, Karlshamn, Karlskoga, Karlskrona, Karlstad, Karolinska, Katrineholm, Kiruna, Kristianstad, Kungälv, Köping, Landskrona, Lidköping, Lindesberg, Linköping, Ljungby, Lund, Lycksele, Malmö, Mora, Motala, Mölndal, Norrköping, Norrtälje, Nyköping, Oskarshamn, Piteå, Sahlgrenska, Skellefteå, Skövde, Sollefteå. St Göran, Sunderbyn, Sundsvall, Södersjukhuset, Södertälje, Torsby, Trelleborg, Trollhättan, Umeå, Uppsala, Varberg, Visby, Värnamo, Västervik, Västerås, Växjö, Ystad, Ängelholm, Örebro, Örnsköldsvik, Östersund, Östra TAVI

20

Annual Report. The Swedish Knee Arthroplasty Register. Dept. of Orthopedics, Skåne University Hospital, Lund

Annual Report. The Swedish Knee Arthroplasty Register. Dept. of Orthopedics, Skåne University Hospital, Lund Akademiska sjukhuset Alingsås Arvika Bollnäs - Söderhamn Borås Carlanderska Danderyd Eksjö-Nässjö Elisabethsjukhuset Enköping Eskilstuna Falköping Falun Frölunda Spec, Sjh, Gällivare Gävle Halmstad Helsingborg

More information

KYON KYON KYON KYON KYON KYON KYON KYON K N KYON KYON KYON KYON KYON KYON KYON KYON KYON KY 256,298 YON KYON KYON KYON KYON KYO

KYON KYON KYON KYON KYON KYON KYON KYON K N KYON KYON KYON KYON KYON KYON KYON KYON KYON KY 256,298 YON KYON KYON KYON KYON KYO 256,298 Alingsås Kungälv Sunderby YO PRIMARY THRs 1979-2005 30,052 REOPERATIONS 1979-2005 (closed reduction excl.) 24,476 REVISIONS 1979-2005 2,079 ENVIRONMENTAL/ TECHNICAL PROFILES 1979-2005 24,192 PATIENT

More information

ORIGINAL INVESTIGATION. Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment Elevation Myocardial Infarction

ORIGINAL INVESTIGATION. Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment Elevation Myocardial Infarction ORIGINAL INVESTIGATION in Patients 75 Years and Older With ST-Segment Elevation Myocardial Infarction One-Year Follow-up of a Large Prospective Cohort Ulf Stenestrand, MD; Lars Wallentin, MD, PhD; for

More information

Depression after stroke is a well-defined entity that is

Depression after stroke is a well-defined entity that is Self-Reported Depression and Use of Antidepressants After Stroke: A National Survey Marie Eriksson, MSc; Kjell Asplund, MD, PhD; Eva-Lotta Glader, MD, PhD; Bo Norrving, MD, PhD; Birgitta Stegmayr, PhD;

More information

THE SCANDINAVIAN SIMVASTAtin

THE SCANDINAVIAN SIMVASTAtin ORIGINAL CONTRIBUTION Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival Ulf Stenestrand, MD Lars Wallentin, MD, PhD for the Swedish Register of Cardiac Intensive Care (RIKS-HIA)

More information

Certificate of Registration

Certificate of Registration Certificate of Registration This is to certify that the management system of Ahlsell Sverige AB Main site: Rosterigränd 12, SE-117 98 Stockholm, Sweden Additional sites according to appendix page 1-8 has

More information

complications do we cause when we operate? Data from The Swedish National Register on Gynecologic Surgery

complications do we cause when we operate? Data from The Swedish National Register on Gynecologic Surgery How many and how serious complications do we cause when we operate? Data from The Swedish National Register on Gynecologic Surgery Jan-Henrik Stjerndahl Ass Prof. MD. PhD. Dept of Obstet & Gynecology Sahlgrenska

More information

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial)

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial) UCR Uppsala Clinical Research Center Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial) Main results at 30 days Ole Fröbert, MD, PhD - on behalf of the TASTE investigators

More information

Annual Report. Lund University Department of Clinical Sciences, Orthopedics Skåne University Hospital, Lund Sweden

Annual Report. Lund University Department of Clinical Sciences, Orthopedics Skåne University Hospital, Lund Sweden Akademiska sjukhuset Alingsås ArtClinic Göteborg ArtClinic Jönköping Arvika Bollnäs Borås Carlanderska Danderyd Eksjö (Höglandssjukh.) Elisabethkliniken Enköping Eskilstuna Falun Gällivare Gävle Halmstad

More information

Annual Report. Lund University Department of Clinical Sciences, Orthopedics Skåne University Hospital, Lund Sweden

Annual Report. Lund University Department of Clinical Sciences, Orthopedics Skåne University Hospital, Lund Sweden Akademiska sjukhuset Alingsås ArtClinic Göteborg ArtClinic Jönköping Arvika Bollnäs Borås Carlanderska Danderyd Eksjö-Nässjö Elisabethkliniken Enköping Eskilstuna Falun Gällivare Gävle Halmstad Helsingborg

More information

Nationella FOTLEDSregistret.

Nationella FOTLEDSregistret. Nationella FOTLEDSregistret www.swedankle.se 2014 Malmö 2015 ISSN: 2001-6697 Ansvarig utgivare: Åke Carlsson Dept. of Orthopaedics Skånes universitetssjukhus, 205 02 MALMÖ. The content protected by copyright

More information

The Swedish Ankle Register. for total ankle replacements and ankle arthrodeses. Nationella FOTLEDSregistret. Annual report for 2012

The Swedish Ankle Register. for total ankle replacements and ankle arthrodeses. Nationella FOTLEDSregistret.   Annual report for 2012 for total ankle replacements and ankle arthrodeses Nationella FOTLEDSregistret www.swedankle.se Malmö August 1, 2013 ISSN: 2001-6697 Ansvarig utgivare: Åke Carlsson, Skånes universitetssjukhus, 205 02

More information

Swedish Hip Arthroplasty Register Annual Report 2010

Swedish Hip Arthroplasty Register Annual Report 2010 Swedish Hip Arthroplasty Register Annual Report 2010 Swedish Hip Arthroplasty Register Annual Report 2010 Göran Garellick Johan Kärrholm Cecilia Rogmark Peter Herberts ISBN 978-91-977112-9-6 ISSN 1654-5982

More information

Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008

Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008 Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008 Marie Eriksson, PhD; Anna Stecksén, MSc; Eva-Lotta Glader, MD; Bo Norrving, MD; Peter Appelros, MD; Kerstin Hulter Åsberg,

More information

Swedish Hip Arthroplasty Register Annual Report 2011

Swedish Hip Arthroplasty Register Annual Report 2011 Swedish Hip Arthroplasty Register Annual Report 2011 Swedish Hip Arthroplasty Register Annual Report 2011 Göran Garellick Johan Kärrholm Cecilia Rogmark Ola Rolfson Peter Herberts ISBN 978-91-980507-1-4

More information

Building regional stroke networks for mechanical thrombectomy. Gunnar Andsberg, MD PhD Neurology, Skånes University Hospital Lund Sweden

Building regional stroke networks for mechanical thrombectomy. Gunnar Andsberg, MD PhD Neurology, Skånes University Hospital Lund Sweden Building regional stroke networks for mechanical thrombectomy Gunnar Andsberg, MD PhD Neurology, Skånes University Hospital Lund Sweden Region Skåne Halmstad Ljungby Växjö Karlskrona Karlshamn Ängelholm

More information

SCAN-B Pilot study in Helsingborg

SCAN-B Pilot study in Helsingborg SCAN-B Pilot study in Helsingborg Martin Malmberg Department of Oncology Christian Brueffer SCAN-B Lao Saal SCAN-B Anna Ehinger Department of Clinical Pathology Lund Dorthe Grabau Johan Vallon Christersson

More information

Swedish ACL Register. Annual Report 2014.

Swedish ACL Register. Annual Report 2014. 1 Swedish ACL Register. Annual Report 2014. www.aclregister.nu 14 ENHANCING HEALTH CARE 2 Contents Preface...3 Goals and goal fulfillment...3 Future vision for Swedish quality register...5 Areas for improvement

More information

Original Contributions. Stroke Units in Their Natural Habitat. Can Results of Randomized Trials Be Reproduced in Routine Clinical Practice?

Original Contributions. Stroke Units in Their Natural Habitat. Can Results of Randomized Trials Be Reproduced in Routine Clinical Practice? Original Contributions Stroke Units in Their Natural Habitat Can Results of Randomized Trials Be Reproduced in Routine Clinical Practice? Birgitta Stegmayr, PhD; Kjell Asplund, MD, PhD; Kerstin Hulter-Åsberg,

More information

The New England Journal of Medicine IMPROVED SURVIVAL WITH PREOPERATIVE RADIOTHERAPY IN RESECTABLE RECTAL CANCER. Randomization

The New England Journal of Medicine IMPROVED SURVIVAL WITH PREOPERATIVE RADIOTHERAPY IN RESECTABLE RECTAL CANCER. Randomization IMPROVED SURVIVAL WITH PREOPERATIVE RADIOTHERAPY IN RESECTABLE RECTAL CANCER SWEDISH RECTAL CANCER TRIAL* ABSTRACT Background Adjuvant radiotherapy for rectal cancer has been extensively studied, but no

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.1016/ Document Version Version created as part of publication process; publisher's layout; not normally made publicly available Link to publication record in King's Research

More information

Although thrombolysis has been amply shown to have a

Although thrombolysis has been amply shown to have a Dissemination of Thrombolysis for Acute Ischemic Stroke Across a Nation Experiences From the Swedish Stroke Register, 2003 to 2008 Marie Eriksson, PhD; Fredrik Jonsson, MSc; Peter Appelros, MD; Kerstin

More information

SwedAnkle The Swedish Ankle Registry Annual Report 2016 Summary in English

SwedAnkle The Swedish Ankle Registry Annual Report 2016 Summary in English SwedAnkle The Swedish Ankle Registry Annual Report 2016 Summary in English [Skriv här] Participating units 2016 Alingsås Borås Carlanderska Sportsmedicin Carlanderska Ortopedi Danderyd Eksjö Elisabethsjukhuset

More information

A Nested Case Control Study on the Risk of Surgical Site Infection After Thyroid Surgery

A Nested Case Control Study on the Risk of Surgical Site Infection After Thyroid Surgery World J Surg (2018) 42:2454 2461 https://doi.org/10.1007/s00268-018-4492-2 ORIGINAL SCIENTIFIC REPORT A Nested Case Control Study on the Risk of Surgical Site Infection After Thyroid Surgery F. A. Salem

More information

SWEDEHEART. Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies

SWEDEHEART. Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies SWEDEHEART Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies Tomas Jernberg TAVI Chairman, SWEDEHEART Karolinska University

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Abstract. Background The long-term safety and efficacy of drug-eluting coronary stents have been questioned.

Abstract. Background The long-term safety and efficacy of drug-eluting coronary stents have been questioned. The new england journal of medicine established in 1812 may 7, 29 vol. 36 no. 19 Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden Stefan K. James, M.D., Ph.D., Ulf Stenestrand,

More information

Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden original article Long-Term Outcomes with Drug-Eluting s versus Bare-Metal s in Sweden Bo Lagerqvist, M.D., Ph.D., Stefan K. James, M.D., Ph.D., Ulf Stenestrand, M.D., Ph.D., Johan Lindbäck, M.Sc., Tage

More information

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work. Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Erlinge D, Omerovic E, Fröbert O, et al. Bivalirudin versus heparin

More information

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes 710 Diabetes Volume 65, March 2016 Lue Ping Zhao, 1 Shehab Alshiekh, 2 Michael Zhao, 1 Annelie Carlsson, 3 Helena Elding Larsson, 2 Gun Forsander, 4 Sten A. Ivarsson, 2 Johnny Ludvigsson, 5 Ingrid Kockum,

More information

Hedenbro, Jan; Näslund, E; Boman, L; Lundegårdh, G; Bylund, A; Ekelund, Mats; Laurenius, A; Möller, P; Olbers, T; Sundbom, M; Ottosson, J; Näslund, I

Hedenbro, Jan; Näslund, E; Boman, L; Lundegårdh, G; Bylund, A; Ekelund, Mats; Laurenius, A; Möller, P; Olbers, T; Sundbom, M; Ottosson, J; Näslund, I Formation of the Scandinavian Obesity Surgery Registry, SOReg. Hedenbro, Jan; Näslund, E; Boman, L; Lundegårdh, G; Bylund, A; Ekelund, Mats; Laurenius, A; Möller, P; Olbers, T; Sundbom, M; Ottosson, J;

More information

Characterisation of influenza outbreaks in Sweden

Characterisation of influenza outbreaks in Sweden Scandinavian Journal of Public Health, 2; : ORIGINAL ARTICLE Characterisation of influenza outbreaks in Sweden LINUS SCHIÖLER Statistical Research Unit, Department of Economics, University of Gothenburg,

More information

F or rheumatoid arthritis (RA) and other chronic inflammatory

F or rheumatoid arthritis (RA) and other chronic inflammatory 1421 EXTENDED REPORT Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists J Askling, C M Fored, L Brandt, E Baecklund, L Bertilsson,

More information

Prevalence of respiratory and hyperreactivity symptoms in relation to levels of criteria air pollutants in Sweden

Prevalence of respiratory and hyperreactivity symptoms in relation to levels of criteria air pollutants in Sweden E N V I R O N M E N T A L H E A L T H Prevalence of respiratory and hyperreactivity symptoms in relation to levels of criteria air pollutants in Sweden BERTH FORSBERG, NILS STJERNBERG t, ST1G WALL ' Our

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

Master Class in Preventive Cardiology. The New MI Phenotype OR. Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden

Master Class in Preventive Cardiology. The New MI Phenotype OR. Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden Master Class in Preventive Cardiology The New MI Phenotype OR Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden The New MI Phenotype OR Coronary disease and glucose abnormalities Klas

More information

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice 10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia

More information

ORIGINAL ARTICLE Bivalirudin versus Heparin Monotherapy in Myocardial Infarction David Erlinge, M.D., Ph.D., Elmir Omerovic, M.D., Ph.D.

ORIGINAL ARTICLE Bivalirudin versus Heparin Monotherapy in Myocardial Infarction David Erlinge, M.D., Ph.D., Elmir Omerovic, M.D., Ph.D. ORIGINAL ARTICLE Bivalirudin versus Heparin Monotherapy in Myocardial Infarction David Erlinge, M.D., Ph.D., Elmir Omerovic, M.D., Ph.D., Ole Fröbert, M.D., Ph.D., Rikard Linder, M.D., Ph.D., Mikael Danielewicz,

More information

Annual Report Scandinavian Quality Register for Thyroid and Parathyroid Surgery. Editor A.Bergenfelz

Annual Report Scandinavian Quality Register for Thyroid and Parathyroid Surgery. Editor A.Bergenfelz Annual Report 9 Scandinavian Quality Register for Thyroid and Parathyroid Surgery Editor A.Bergenfelz Anders Bergenfelz Printed by Media-Tryck, Lund ISBN 978-91-978553-2-7 Contents 1. Participating Units

More information

Oxygen Therapy in Suspected Acute Myocardial Infarction

Oxygen Therapy in Suspected Acute Myocardial Infarction The new england journal of medicine Original Article Oxygen Therapy in Suspected Acute Myocardial Infarction Robin Hofmann, M.D., Stefan K. James, M.D., Ph.D., Tomas Jernberg, M.D., Ph.D., Bertil Lindahl,

More information

Joo-Yong Hahn, MD/PhD

Joo-Yong Hahn, MD/PhD Sungkyunkwan University School of Medicine Joo-Yong Hahn, MD/PhD Heart Vascular Stork Institute, Samsung Medical Center Sungkyunkwan University School of Medicine Grant support Korean Society of Interventional

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End- Stage Renal Disease

Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End- Stage Renal Disease Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End- Stage Renal Disease A nationwide population-based

More information

Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction

Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction The new england journal of medicine original article Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction Bo Lagerqvist, M.D., Ph.D., Ole Fröbert, M.D., Ph.D., Göran K. Olivecrona, M.D.,

More information

ALTHOUGH RECENT POPULAtion-based

ALTHOUGH RECENT POPULAtion-based ORIGINAL CONTRIBUTION Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction Tomas Jernberg, MD, PhD Per Johanson, MD, PhD Claes Held,

More information

Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents

Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents Diabetologia (2013) 56:1735 1742 DOI 10.1007/s00125-013-2934-9 ARTICLE Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction The new england journal of medicine Original Article versus Monotherapy in Myocardial Infarction D. Erlinge, E. Omerovic, O. Fröbert, R. Linder, M. Danielewicz, M. Hamid, E. Swahn, L. Henareh, H. Wagner,

More information

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction Original Article versus Monotherapy in Myocardial Infarction D. Erlinge, E. Omerovic, O. Fröbert, R. Linder, M. Danielewicz, M. Hamid, E. Swahn, L. Henareh, H. Wagner, P. Hårdhammar, I. Sjögren, J. Stewart,

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

Patients surviving an acute myocardial infarction (AMI)

Patients surviving an acute myocardial infarction (AMI) Mortality After Ischemic in Patients With Acute Myocardial Infarction Predictors and Trends Over Time in Sweden Anna Brammås; Stina Jakobsson; Anders Ulvenstam, MD; Thomas Mooe, MD, PhD Background and

More information

VENOUS THROMBOEMBOLISM IN WOMEN AN ASSESSMENT OF HORMONAL, GENETIC AND OTHER RISK FACTORS

VENOUS THROMBOEMBOLISM IN WOMEN AN ASSESSMENT OF HORMONAL, GENETIC AND OTHER RISK FACTORS From the Department of Medicine Solna Centre for Pharmacoepidemiology Karolinska Institutet, Stockholm, Sweden VENOUS THROMBOEMBOLISM IN WOMEN AN ASSESSMENT OF HORMONAL, GENETIC AND OTHER RISK FACTORS

More information

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME DEPARTMENT OF CLINICAL SCIENCE AND EDUCATION, SÖDERSJUKHUSET Karolinska Institutet, Stockholm, Sweden EARLY DIAGNOSIS AND RISK STRATIFICATION IN PATIENTS WITH SYMPTOMS SUGGESTIVE OF ACUTE CORONARY SYNDROME

More information

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists 1414 EXTENDED REPORT Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists J Askling, C M Fored, E Baecklund, L Brandt,

More information

International Journal of Pharma and Bio Sciences STUDY OF SERUM URIC ACID LEVELS IN ACUTE MYOCARDIAL INFARCTION ABSTRACT

International Journal of Pharma and Bio Sciences STUDY OF SERUM URIC ACID LEVELS IN ACUTE MYOCARDIAL INFARCTION ABSTRACT Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 STUDY OF SERUM URIC ACID LEVELS IN ACUTE MYOCARDIAL INFARCTION DR. ABHISHEK DAS*, DR. DHANDAPANI E., DR. ARUN

More information

Endovascular and open surgery for acute occlusion of the superior mesenteric artery

Endovascular and open surgery for acute occlusion of the superior mesenteric artery Endovascular and open surgery for acute occlusion of the superior mesenteric artery Tomas A. Block, MD, a Stefan Acosta, MD, PhD, b and Martin Björck, MD, PhD, c Stockholm, Malmö, and Uppsala, Sweden Background:

More information

Optimal blockade of the Renin- Angiotensin-Aldosterone. in chronic heart failure

Optimal blockade of the Renin- Angiotensin-Aldosterone. in chronic heart failure Optimal blockade of the Renin- Angiotensin-Aldosterone Aldosterone- (RAA)-System in chronic heart failure Jan Östergren Department of Medicine Karolinska University Hospital Stockholm, Sweden Key Issues

More information

C. David Sjostrom, * Lauren Lissner, f Hans Wedel,$ and Lars Sjostrom-f- Introduction

C. David Sjostrom, * Lauren Lissner, f Hans Wedel,$ and Lars Sjostrom-f- Introduction Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study C. David Sjostrom, * Lauren Lissner, f Hans

More information

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure

More information

Subsequent management and therapies

Subsequent management and therapies ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY

More information

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital Heart Failure and COPD: Common Partners, Common Problems Nat Hawkins Liverpool Heart and Chest Hospital Disclosures: No conflicts of interest Common partners, common problems COPD in HF common partners

More information

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION?

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? Doron Zahger, MD Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST How to manage antiplatelet treatment in patients with diabetes in acute coronary syndrome Lars Wallentin Professor of Cardiology, Chief Researcher Cardiovascular Science

More information

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Early discharge in selected patients after an acute coronary syndrome can it be safe? Early discharge in selected patients after an acute coronary syndrome can it be safe? Glória Abreu, Pedro Azevedo, Carina Arantes, Catarina Quina-Rodrigues, Sara Fonseca, Juliana Martins, Catarina Vieira,

More information

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung, MD, PhD; Magnus Johansson, MD, PhD; Martin Holzmann,

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

Ischemic stroke is an important and potentially devastating

Ischemic stroke is an important and potentially devastating Incidence, Trends, and Predictors of Ischemic 1 Year After an Acute Myocardial Infarction Anders Ulvenstam, MD; Ulf Kajermo, MD; Angelo Modica, MD, PhD; Tomas Jernberg, MD, PhD; Lars Söderström, MSc; Thomas

More information

SwedAnkle The Swedish Ankle Registry Annual Report 2017 Summary in English

SwedAnkle The Swedish Ankle Registry Annual Report 2017 Summary in English SwedAnkle The Swedish Ankle Registry Annual Report 2017 Summary in English www.swedankle.se Participating units 2017 Alingsås Borås Carlanderska Sportsmedicin Carlanderska Ortopedi Danderyd Eksjö Elisabethsjukhuset

More information

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Patient Navigator Program: Focus MI Diplomat Hospital Metrics Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture

More information

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Material to Mayer et al. A comparative cohort study on personalised Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass

More information

Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction

Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction Holger Thiele, MD; Konrad Kubusch, BSc; Steffen Desch,

More information

Adrenal incidentaloma follow-up results from a Swedish prospective study

Adrenal incidentaloma follow-up results from a Swedish prospective study European Journal of Endocrinology (2006) 154 419 423 ISSN 0804-4643 CLINICAL STUDY Adrenal incidentaloma follow-up results from a Swedish prospective study Birgitta Bülow, Svante Jansson 1, Claes Juhlin

More information

Lars Norgren, MD, PhD, FRCS, for the Swedish EnoxaVasc Study Group

Lars Norgren, MD, PhD, FRCS, for the Swedish EnoxaVasc Study Group Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial Lars Norgren, MD, PhD, FRCS, for the Swedish

More information

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment Journal of the American College of Cardiology Vol. 55, No. 13, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.01.013

More information

Manifestations and Survival in Coronary Heart Disease

Manifestations and Survival in Coronary Heart Disease From the Department of Emergency and Cardiovascular Medicine, Sahlgrenska University Hospital/Östra, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Manifestations

More information

I have nothing to disclose.

I have nothing to disclose. I have nothing to disclose. Chest Pain Units in Europe Thomas Münzel, Mainz, Germany Clinic Dome Mainz 05 Death Rate Cardiovascular Disease - Europe- About 44% Robert Koch Institut, Gesundheitsbericht

More information

Impact of in-hospital delay to invasive treatment of NSTEMI patients on early and 12-month clinical outcomes

Impact of in-hospital delay to invasive treatment of NSTEMI patients on early and 12-month clinical outcomes Impact of in-hospital delay to invasive treatment of NSTEMI patients on early and 12-month clinical outcomes Analysis from the PL-ACS Registry Marek Gierlotka 1, Grzegorz Opolski 2, Lech Poloński 1, Marcin

More information

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome N.Μoschos, A.Dimitra, E.Tsakiri, D.Stavrianakis, A.Nouli CARDIOLOGY DEPARTMENT

More information

Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial

Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial Olivecrona et al. BMC Cardiovascular Disorders (2016) 16:62 DOI 10.1186/s12872-016-0238-y RESEARCH ARTICLE Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite

More information

RISKS OF SOLID CANCERS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND FOLLOWING TREATMENT WITH TNF-ANTAGONISTS

RISKS OF SOLID CANCERS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND FOLLOWING TREATMENT WITH TNF-ANTAGONISTS ARD Online First, published on April 13, 2005 as 10.1136/ard.2004.033993 RISKS OF SOLID CANCERS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND FOLLOWING TREATMENT WITH TNF-ANTAGONISTS Johan Askling 1,2 C. Michael

More information

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Sheng-Chia Chung, Rolf Gedeborg, Owen Nicholas, Stefan James, Anders Jeppsson, Charles

More information

INCIDENCE OF CANCER AFTER PROPHYLAXIS WITH WARFARIN AGAINST RECURRENT VENOUS THROMBOEMBOLISM

INCIDENCE OF CANCER AFTER PROPHYLAXIS WITH WARFARIN AGAINST RECURRENT VENOUS THROMBOEMBOLISM INCIDENCE OF CANCER AFTER PROPHYLAXIS WITH WARFARIN AGAINST RECURRENT VENOUS THROMBOEMBOLISM INCIDENCE OF CANCER AFTER PROPHYLAXIS WITH WARFARIN AGAINST RECURRENT VENOUS THROMBOEMBOLISM SAM SCHULMAN, M.D.,

More information

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Sheng-Chia Chung, Rolf Gedeborg, Owen Nicholas, Stefan James, Anders Jeppsson, Charles

More information

Diabetes Care 35: , 2012

Diabetes Care 35: , 2012 Epidemiology/Health Services Research O R I G I N A L A R T I C L E Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Changes from 1985 to 2008 SJOERD T.

More information

LUP. Lund University Publications. Institutional Repository of Lund University

LUP. Lund University Publications. Institutional Repository of Lund University LUP Lund University Publications Institutional Repository of Lund University This is an author produced version of a paper published in Journal of the American College of Cardiology. This paper has been

More information

National registries for quality improvement and research

National registries for quality improvement and research Swedish experiences: National registries for quality improvement and research Stefan James Professor of Cardiology Uppsala Clinical Research Centre Uppsala University Uppsala, Sweden Evidence based health

More information

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,

More information

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension (2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with

More information

TAVR or SAVR A glimpse into the future

TAVR or SAVR A glimpse into the future TAVR or SAVR A glimpse into the future Örjan Friberg Örebro University Hospital Sweden Prediction is very difficult, especially if it s about the future. Niels Bohr None Conflicts of interest If In the

More information

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006 Management of Hypertension in Patients with CAD M. Mohsen Ibrahim, MD Cardiology Department- Cairo University 1. What is the optimal BP in patients with hypertension and CAD? 2. What is the minimum safe

More information

Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients

Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients Eur J Hueniurol IYY4: 53: 207-212 Priiirrd 111 Brlyiuiii - rill riyhrs reserved Cop,vrighr 0 Munksguurd I994 EUROPEAN JOURNAL OF HAEMATOLOGY ISSN 09024441 Renal function in newly diagnosed multiple myeloma

More information

Patient-Centered Primary Care Scorecard Measures

Patient-Centered Primary Care Scorecard Measures Patient-Centered Primary Care Scorecard Measures Acute and Chronic Care Management Measures Medication Adherence Proportion of Days Covered (PDC): Oral Diabetes Identifies patients with at least two prescriptions

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schultz JK, Yaqub S, Wallon C, et al. Laparoscopic lavage vs primary resection for acute perforated diverticulitis: the SCANDIV randomized clinical trial. JAMA. doi:10.1001/jama.2015.12076

More information

ABSTRACT. n engl j med 369;17 nejm.org october 24,

ABSTRACT. n engl j med 369;17 nejm.org october 24, The new england journal of medicine established in 1812 october 24, 2013 vol. 369 no. 17 Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction Ole Fröbert, M.D., Ph.D., Bo Lagerqvist, M.D.,

More information

Semilogarithmic relation between rest heart rate and life expectancy

Semilogarithmic relation between rest heart rate and life expectancy The importance of heart rate in heart failure Karl Swedberg Professor of Medicine Department t of emergency and cardiovascular medicine i Sahlgrenska Academy University of Gothenburg, Sweden karl.swedberg@gu.se

More information

Joakim Alfredsson, Johan Lindbäck, Lars Wallentin and Eva Swahn. Linköping University Post Print

Joakim Alfredsson, Johan Lindbäck, Lars Wallentin and Eva Swahn. Linköping University Post Print Similar outcome with an invasive strategy in men and women with non-st-elevation acute coronary syndromes From the Swedish Web- System for Enhancement and Development of Evidence-Based Care in Heart Disease

More information